logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울행정법원 2020.12.18 2019구합89128
입찰참가자격제한처분취소
Text

The plaintiff's claim is dismissed.

Litigation costs shall be borne by the plaintiff.

Reasons

1. Details of the disposition;

A. The Plaintiff is a stock company established on August 27, 2009 for the purpose of software development and supply business, and is mainly engaged in the business of developing and maintaining medical systems and software related to the construction of hospital information systems.

(2) B. 1. 201: 1. 206: 20. 1. 206: 20. 21. 20. 206. 3. 1. 20, 2016. 3. 1. 20, 2016. 3. 1. 20, 201. 3. 20, 2016. 3. 3. 20, 2016. 3. 3. 20, 2016. 3. 20, 2016. 3. 1. 20, 2016. 3. 3. 20, 2016. 3. 3. 20, 2016. 3. 3. 16. 201, 2016. 3. 3. 14. 2016. 3

B. On December 2, 2013, to January 2018, the Plaintiff led to collusion by 12 bidding (hereinafter “each bidding of this case”) with respect to the operation, etc. of the electronic medical record system of the National Hospital. As indicated below, the Fair Trade Commission made each resolution on corrective order, penalty surcharge, and accusation against the Plaintiff’s act of collusion (hereinafter “each resolution of this case”), and exempted or mitigated each of the above dispositions on the grounds that the Plaintiff’s voluntary report was filed on the same day.

The Fair Trade Commission shall make a voluntary report on July 23, 2019 and the E, the Fair Trade Commission shall make a resolution on July 23, 2019 and theO of the Resolution and the Fair Trade Commission on August 6, 2019.

arrow